We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The Association of Microplastics in Peripheral Blood and Pulmonary Disease: A Pilot Study
AI summary Read the abstract
Researchers conducted a pilot case-control study finding that patients with COPD or pulmonary fibrosis had significantly higher circulating microplastic concentrations than healthy controls — median 26.0 versus 3.5 particles per 100 µL — with sub-10 µm particles remaining independently associated with lung disease after adjusting for smoking history.
Microplastics may pose health risks, particularly for chronic lung diseases. Clarifying the link between circulating microplastics and pulmonary disease is vital for shaping research and interventions. The objective of this study was to evaluate whether microplastics in peripheral blood are associated with COPD or IPF vs. no lung disease. In this pilot prospective case-control study, participants were grouped as control (n = 10), COPD (n = 9), or IPF (n = 10). Relevant comorbidities and exposures were obtained from records and questionnaires. All underwent standardized blood collection (PlasticTox©). Samples were analyzed for total microplastic concentration, stratified by size (<10 µm, 10–30 µm, 30–70 µm). The primary outcome was to show a difference in total microplastic burden between lung disease and controls. Secondary measures were to determine size-specific concentrations and associations with demographic variables and smoking history. Among 29 participants (median age 70 (IQR 64–80); 14 women (48.3%)), COPD/IPF groups had significantly higher total microplastic concentrations vs. controls (median 26.0 vs. 3.5 particles/100 µL; p < 0.01). Particle burdens <10 µm and 10–30 µm were particularly elevated (both p < 0.01). After adjusting for smoking, only the <10 µm fraction remained independently associated with lung disease (adjusted odds ratio 1.94 (95% CI, 1.23–7.04)). In this pilot exploratory study, individuals with COPD or IPF showed greater circulating microplastic levels than controls. These findings should be interpreted as hypothesis-generating, and larger analytically validated studies are needed to clarify directionality, causal mechanisms, contamination control, and the clinical relevance of circulating microplastic burden.
More Papers Like This
Investigation of the presence of microplastics and their clinical significance in patients with exacerbation and stable periods of chronic obstructive pulmonary disease
AI summary Read the abstract
Researchers examined the presence of microplastics in sputum and bronchoalveolar lavage samples from chronic obstructive pulmonary disease (COPD) patients during exacerbation and stable phases. MPs were detected in a majority of patient samples, and their presence was associated with greater airway inflammation, suggesting inhaled microplastics contribute to COPD pathology.
Higher respiratory microplastic burden in patients with lung malignancy: A prospective bronchoscopy study.
AI summary Read the abstract
Researchers examined lung fluid and tissue samples from 100 adults undergoing bronchoscopy, comparing 50 patients with newly diagnosed lung cancer to 50 without. Suspected microplastic particles were found in most patients, and were more common and numerous in those with lung malignancy, even after accounting for age, sex and smoking history.
Microplastics in the Lung Tissues Associated with Blood Test Index
AI summary Read the abstract
Researchers analyzed lung tissue from 12 nonsmoking patients and found microplastics in all samples, with 12 different plastic types detected and polypropylene being the most common. Women and people living near major roads had higher microplastic levels in their lungs, and the amounts correlated with changes in blood clotting markers. This study provides direct evidence that microplastics accumulate in human lungs and may affect blood health, even in people who have never smoked.
Microplastics, potential threat to patients with lung diseases
AI summary Read the abstract
This review examines the potential threat that airborne microplastics pose to people with existing lung conditions, noting that these particles have been found in human lung tissue and sputum. Researchers explored possible mechanisms by which inhaled microplastics could worsen lung diseases, including triggering inflammation and oxidative stress. The study highlights significant knowledge gaps and calls for more research into how microplastic inhalation affects respiratory health.
Potential toxicity of micro- and nanoplastics in primary bronchial epithelial cells of patients with chronic obstructive pulmonary disease
AI summary Read the abstract
Researchers investigated how micro- and nanoplastics affect lung cells taken from patients with chronic obstructive pulmonary disease (COPD), a condition that already impairs breathing. The study aimed to determine whether plastic particle exposure poses additional toxic risk to people whose airways are already compromised.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.